New York ’s Memorial Sloan - Kettering Cancer Center is giving patient trackers to blood - cancer patients to monitor their reactions to treatment . The hospital is one of several turning to wearable tech to create data that will help develop and personalise medical - care plans . Although the data collected is n't accurate enough for clinical use , it does offer an insight into " general trends " and can be useful . One small study used Fitbits to determine whether patients were healthy enough to undergo chemotherapy , while another attempted to establish a link between weight loss and improved survival rates in breast cancer .
New York’s Memorial Sloan-Kettering Cancer Center is giving fitness trackers to blood-cancer patients to monitor their reactions to treatment. The hospital is one of several turning to wearable tech to create data that will help streamline and personalise medical-care plans. Although the data generated isn't accurate enough for clinical use, it does offer an insight into "general trends" and can be useful. One small study used Fitbits to determine whether patients were healthy enough to undergo chemotherapy, while another tried to establish a link between weight loss and improved survival rates in breast cancer.